Skip to main content
. 2015 May 11;125(6):2510–2522. doi: 10.1172/JCI80025

Figure 3. PCSK9 kinetics after treatment with anacetrapib.

Figure 3

PCSK9 kinetic parameters for subjects in panel A (n = 29) and panel B (n = 10) at the end of each treatment period. The geometric mean is shown as a bar. None of the comparisons achieved a raw P value of less than 0.05 on the basis of the linear mixed-effects models containing fixed effects for panel and treatment-within-panel and random effects for subject-within-panel.